Kennesaw State University   Report issue

Academic/Hospital
Founded: Kennesaw GA United States (1963)

Organization Overview

First Clinical Trial
2016
NCT04083521
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kennesaw State University

Active Ingredients

Drugs in Other Trials (3)

bacillus subtilis (1 trial)

quercetin (1 trial)

solarplast (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 3